Haemonetics stock trades down to 84.82 as Haemonetics Corporation issues ADLM 2026 outreach invite

Traders Union
All News
Business & Wealth
Companies
Haemonetics down 0.70% today

Highlights

HAE maintains a strong uptrend, trading well above major moving averages and confirming persistent bullish momentum.
Momentum indicators are deeply overbought, indicating robust buying pressure but raising the risk of a short-term pullback.
Next week’s forecasted trading range is $82.68 to $85.12, with breakout potential toward the 52-week high if resistance is cleared.

Haemonetics stated it valued the opportunity to share how its technologies integrate into existing laboratory workflows. The company invited those who did not connect at the event to reach out.

View post on X Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Bullish momentum sustained as price holds above major moving averages

HAE is trading well above its key moving averages, with the current price of $84.82 situated above the MA-20 ($77.87), MA-50 ($73.95), and MA-200 ($67.45), confirming persistent bullish momentum across the short, medium, and long-term timeframes. The Ichimoku Kijun level on D1 is $78.76, which sits below the current price and functions as immediate support; near-term support is found at MA-20 ($77.87) and Ichimoku Kijun ($78.76), with key support at MA-50 ($73.95), while near-term resistance is MA-5 ($82.29) with key resistance at the recent weekly high ($85.71).

Overbought signals and strong gains fuel risk of short-term pullbacks

Momentum indicators on D1 remain strongly bullish, with MACD and ADX both signaling upward strength, while RSI (72.87), Stoch RSI (88.22), and CCI (195.16) all suggest pronounced overbought conditions. BBP’s positive value (4.76) confirms persistent buyer dominance intraday, and the Awesome Oscillator is supportive of the current bullish trend. Over the past week, HAE has climbed $6.04 (7.67%) from last week’s close of $78.78, placing the price at the very top of the weekly range and keeping volatility elevated at 10.92%. This marks a robust recovery from the weekly low, with momentum signals confirming the recent upside, though the overextension in oscillators suggests caution due to an increased risk of short-term pullbacks.

High upside probability expected as buy signals cluster near resistance

Looking ahead, the expected trading range for the coming week is $82.68 to $85.12, keeping the price anchored just below the 52-week high ($87.32) and well above the yearly low ($47.32). The probability of a further price increase is very high (more than 80%) according to the alignment of Buy signals on RSI-W1, MACD-W1, ADX-W1, and MA-50-W1, making a downside move less likely. The baseline scenario calls for consolidation within the $82.68–$85.12 corridor. A bullish breakout above resistance could target the 52-week high, while a bearish scenario would see the price slip below immediate support into the upper-$70s range.

Previously it was reported that Haemonetics was demonstrating strong bullish momentum while consolidating near annual highs. With new developments and price action since that assessment, investors should closely monitor for a sustained breakout or breakdown to identify the prevailing scenario in the sessions ahead.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.